Charles Okot Odongo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Charles Okot Odongo has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Abebe Bekele
University of Global Health Equity, Kigali, Rwanda
1 shared publicationAbebe Moges Muche
University of Global Health Equity, Kigali, Rwanda
1 shared publicationArlene Nishimwe
University of Global Health Equity, Kigali, Rwanda
1 shared publication- Clovis Gatete Nkeramihigo
Division of Basic Medical Sciences, School of Medicine, University of Global Health Equity, Kigali P.O. Box 6955, Rwanda
1 shared publication Daniel Seifu
University of Global Health Equity, Kigali, Rwanda
1 shared publication- Daniel Seifu
Biochemistry, University of Global Health Equity, Kigali, RWA
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 25 (1) , 1-11
The viva voce innovation and experience at a new medical school in Rwanda
Traditional preclinical viva voce examinations have faced significant criticism due to inherent biases in their format. We developed a novel format and evaluated students’ views and experiences with it. This study consists of two parts. Part 1 describes the development, implementation and refinement of the preclinical viva voce examination at the University of Global Health Equity, in Rwanda, conducted over a four-year period. Part 2 describes students’ perspectives obtained through a self-administered online questionnaire. Part 1: The viva format features structured questions related to authentic clinical scenarios, that underscore the relevance of basic science knowledge to clinical practice. The examination consists of three oral stations plus one image-based station, which targets subjects that are traditionally difficult to examine like embryology, histology, and histopathology. The examination is vertically and horizontally integrated and provides students with multiple opportunities to demonstrate their knowledge. With four or more rotations of this kind, students are simultaneously examined, improving time efficiency, and reducing performance fatigue normally associated with long waiting times. Real-time scoring and commenting on individual student performances on shared files ensure examiner transparency and accountability, reducing bias. The examination ends with a faculty debrief conference, after which students receive individual feedback on their performance. Challenges encountered include examiner preferences for cases and the need for a substantial number of faculty to concurrently manage the numerous viva stations. Part 2: Students reported finding the viva format stressful but acknowledged its long-term benefits, including ability to foster mental agility, promote clinical reasoning, and improve their verbal communication skills. Compared to MCQ assessments, many students felt it was a better way of assessing knowledge, as it eliminated guesswork. Group discussions were identified as the most effective viva preparation strategy. Many students expressed a desire for more supportive interactions from examiners during the viva. Despite these challenges, there was broad agreement that the viva format should be retained. The novel preclinical viva format described here enhances the reliability and validity of assessment while providing formative support and early clinical integration. It represents a balanced approach to addressing traditional viva limitations while maintaining educational value.
- 1 July 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 25 (1) , 1-11
Open AccessThe viva voce innovation and experience at a new medical school in Rwanda
Traditional preclinical viva voce examinations have faced significant criticism due to inherent biases in their format. We developed a novel format and evaluated students’ views and experiences with it. This study consists of two parts. Part 1 describes the development, implementation and refinement of the preclinical viva voce examination at the University of Global Health Equity, in Rwanda, conducted over a four-year period. Part 2 describes students’ perspectives obtained through a self-administered online questionnaire. Part 1: The viva format features structured questions related to authentic clinical scenarios, that underscore the relevance of basic science knowledge to clinical practice. The examination consists of three oral stations plus one image-based station, which targets subjects that are traditionally difficult to examine like embryology, histology, and histopathology. The examination is vertically and horizontally integrated and provides students with multiple opportunities to demonstrate their knowledge. With four or more rotations of this kind, students are simultaneously examined, improving time efficiency, and reducing performance fatigue normally associated with long waiting times. Real-time scoring and commenting on individual student performances on shared files ensure examiner transparency and accountability, reducing bias. The examination ends with a faculty debrief conference, after which students receive individual feedback on their performance. Challenges encountered include examiner preferences for cases and the need for a substantial number of faculty to concurrently manage the numerous viva stations. Part 2: Students reported finding the viva format stressful but acknowledged its long-term benefits, including ability to foster mental agility, promote clinical reasoning, and improve their verbal communication skills. Compared to MCQ assessments, many students felt it was a better way of assessing knowledge, as it eliminated guesswork. Group discussions were identified as the most effective viva preparation strategy. Many students expressed a desire for more supportive interactions from examiners during the viva. Despite these challenges, there was broad agreement that the viva format should be retained. The novel preclinical viva format described here enhances the reliability and validity of assessment while providing formative support and early clinical integration. It represents a balanced approach to addressing traditional viva limitations while maintaining educational value.
- Open Access
- 6 October 2024
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 24 (3) , 21-29
Diversity and antibiotic sensitivity of uropathogens from a regional hospital in Rwanda
Background: Urinary tract infections are a common cause for antibiotic consumption. Empirical treatment is common for community-acquired infections owing to predictability of pathogens. Objectives: Describe sensitivity profiles of uropathogens at a regional hospital in Rwanda. Methods: Hospital-based cross-sectional study in which clean-catch urine samples were analyzed. A two-stage process involving dipstick urinalysis and urine culture was used to identify true infections. The Kirby-Bauer disc diffusion method was used for antibiotic sensitivity analysis as per EUCAST guidelines. Results: Of 198 samples studied, 107 met criterion for UTI with 94 yielding significant growth. Klebsiella pneumoniae (35%), and Escherichia coli (32%) were the most common organisms isolated. Others included Staphylococcal species, Proteus spp, Enterobacter spp and Salmonella. Very high resistance frequencies (above 70%) were observed against amoxycillin, cotrimoxazole, trimethoprim, aztreonam and fosfomycin. Resistance to fluoroquinolones, aminoglycosides and cephalosporins varied between 40-60%. High levels of cross resistance were observed for drugs of the same class. Resistance to the potentiated penicillins, meropenem, cefoxitin and nitrofurantoin were less than 30%. Piperacillintazo bactum performed best with 91% sensitivity against all organisms tested. Conclusion: High levels of resistance were observed for most antibiotics studied. For empirical treatment of community-acquired UTI in our setting, nitrofurantoin remains effective while ciprofloxacin is not. Keywords: Diversity and antibiotic sensitivity; uropathogens; Rwanda.
- 6 October 2024
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 24 (3) , 21-29
Open AccessDiversity and antibiotic sensitivity of uropathogens from a regional hospital in Rwanda
Background: Urinary tract infections are a common cause for antibiotic consumption. Empirical treatment is common for community-acquired infections owing to predictability of pathogens. Objectives: Describe sensitivity profiles of uropathogens at a regional hospital in Rwanda. Methods: Hospital-based cross-sectional study in which clean-catch urine samples were analyzed. A two-stage process involving dipstick urinalysis and urine culture was used to identify true infections. The Kirby-Bauer disc diffusion method was used for antibiotic sensitivity analysis as per EUCAST guidelines. Results: Of 198 samples studied, 107 met criterion for UTI with 94 yielding significant growth. Klebsiella pneumoniae (35%), and Escherichia coli (32%) were the most common organisms isolated. Others included Staphylococcal species, Proteus spp, Enterobacter spp and Salmonella. Very high resistance frequencies (above 70%) were observed against amoxycillin, cotrimoxazole, trimethoprim, aztreonam and fosfomycin. Resistance to fluoroquinolones, aminoglycosides and cephalosporins varied between 40-60%. High levels of cross resistance were observed for drugs of the same class. Resistance to the potentiated penicillins, meropenem, cefoxitin and nitrofurantoin were less than 30%. Piperacillintazo bactum performed best with 91% sensitivity against all organisms tested. Conclusion: High levels of resistance were observed for most antibiotics studied. For empirical treatment of community-acquired UTI in our setting, nitrofurantoin remains effective while ciprofloxacin is not. Keywords: Diversity and antibiotic sensitivity; uropathogens; Rwanda.
- Open Access
- 5 July 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (7) , 895
Towards Improved Management of Tuberculous Bloodstream Infections: Pharmacokinetic Considerations with Suggestions for Better Treatment Outcomes
Mycobacterium tuberculosis is the leading cause of sepsis among HIV-infected adults, yet effective treatment remains a challenge. Efficacy of antituberculous drugs is optimized by high Area Under Curve to Minimum Inhibitory Concentration (AUC/MIC) ratios, suggesting that both the drug concentration at the disease site and time above MIC are critical to treatment outcomes. We elaborate on sepsis pathophysiology and show how it adversely affects antituberculous drug kinetics. Expanding distribution volumes secondary to an increased vascular permeability prevents the attainment of target Cmax concentrations for nearly all drugs. Furthermore, sepsis-induced metabolic acidosis promotes protonation, which increases renal clearance of basic drugs such as isoniazid and ethambutol, and hence AUCs are substantially reduced. Compared with the treatment of non-sepsis TB disease, these distorted kinetics underlie the poor treatment outcomes observed with bloodstream infections. In addition to aggressive hemodynamic management, an increase in both the dose and frequency of drug administration are warranted, at least in the early phase of treatment.
- 5 July 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (7) , 895
Open AccessTowards Improved Management of Tuberculous Bloodstream Infections: Pharmacokinetic Considerations with Suggestions for Better Treatment Outcomes
Mycobacterium tuberculosis is the leading cause of sepsis among HIV-infected adults, yet effective treatment remains a challenge. Efficacy of antituberculous drugs is optimized by high Area Under Curve to Minimum Inhibitory Concentration (AUC/MIC) ratios, suggesting that both the drug concentration at the disease site and time above MIC are critical to treatment outcomes. We elaborate on sepsis pathophysiology and show how it adversely affects antituberculous drug kinetics. Expanding distribution volumes secondary to an increased vascular permeability prevents the attainment of target Cmax concentrations for nearly all drugs. Furthermore, sepsis-induced metabolic acidosis promotes protonation, which increases renal clearance of basic drugs such as isoniazid and ethambutol, and hence AUCs are substantially reduced. Compared with the treatment of non-sepsis TB disease, these distorted kinetics underlie the poor treatment outcomes observed with bloodstream infections. In addition to aggressive hemodynamic management, an increase in both the dose and frequency of drug administration are warranted, at least in the early phase of treatment.